Monthly Archives: April 2014

Space station's Robonaut awaits delivery of legs

Posted: April 17, 2014 at 3:45 pm

A humanoid "Robonaut" launched to the International Space Station in 2011 will finally receive its space legs when SpaceX's Dragon cargo carrier arrives at the complex, allowing engineers to experiment with the full breadth of the robot's capabilities.

A ground version of Robonaut 2 undergoes testing with its legs. Photo credit: NASA The two legs are loaded inside the Dragon spacecraft's pressurized cargo cabin, ready for launch atop a Falcon 9 rocket. Liftoff is scheduled as soon as Friday.

The legs will give Robonaut 2, the space station's humanoid robot, mobility inside the space station's modules. Officials eventually plan to test the robot outside the station, once it receives upgrades to its upper body.

The dextrous robot, also called R2, includes a computerized torso, head and two arms with hands and five fingers. It is designed to accomplish many of the same upkeep tasks astronauts do every day aboard the space station.

"Robonaut is an example of how we can use robots for repetitive and dangerous tasks in space," said Andy Petro, head of NASA's small satellite technology development program.

According to NASA, the legs will be unpacked and attached to Robonaut 2 by the end of June, with an eye toward testing the assembled robot within the confines of the space station's pressurized modules later this year.

"We call them legs," Petro said. "They're not really for walking in the zero gravity environment. They're used for climbing around."

The legs have seven joints and stretch out to a length of 9 feet to give Robonaut flexibility when moving around the station.

"At the end, instead of feet, they have clamping devices to allow them to connect to handrails and other objects on the space station," Petro said.

Robonaut's use of its legs for climbing frees up its hands and fingers for finer tasks, such as working with tools or repairing systems.

More:
Space station's Robonaut awaits delivery of legs

Posted in Space Station | Comments Off on Space station's Robonaut awaits delivery of legs

NASA Astronauts Bring Wonder of International Space Station to Indianapolis

Posted: at 3:45 pm

Ever wonder what it's like to be an astronaut and to live and work in space? Find out directly from NASA astronauts who will be in theIndianapolisarea fromApril 24 to May 2as the agency shares the accomplishments, promise and opportunities for research aboard the International Space Station.

NASA astronautsAnna Fisher,Serena AunonandScott Tinglewill deliver presentations during the week. All include media availabilities.

In addition, the agency's newest exhibit, Destination Station, a multimedia exhibit showcasing what it's like to live aboard the International Space Station, is open to the public throughJune 29at the Indiana State Museum.

NASA engineer on the Z-2 spacesuit andPurdue UniversitygraduateIan Meginnisand NASA photographerMark Sowawill host a discussion from6-8 p.m.onApril 24at the Museum of Art inIndianapolis. They will discuss NASA's wearable technology and photography in support of the space station.

OnApril 26, as visitors learn more about our home planet atEarth DayIndiana, they also will have the opportunity to experience one of only eight moon rocks in the world that visitors can touch. Located at the White River State Park, NASA'sDriven to Exploremobile exhibit will be atEarth DayIndiana from11 a.m. to 4 p.m.TheEarth Dayfestivities are conveniently located near the Indiana State Museum so visitors can also take a look at the Destination Station exhibit.

Join Aunon, a medical doctor and member of the 2009 astronaut class, as she discusses "Staying Healthy and Fit in Space." Her presentation is fromnoon-2 p.m.April 26at the Indiana State Fairgrounds, Exposition Hall for the WTHR Health and Fitness Expo. Aunon also will teach visitors how to "Train Like an Astronaut" at the Expo the following day,April 27. Various events will begin at11 a.m.

There will be a live, interactive television event with crew members now in space aboard the International Space Station onTuesday, April 29, at the Children's Museum ofIndianapolis. During the activities, which begin at9 a.m., attendees may ask Expedition 39 flight engineersRick Mastracchio,Steve SwansonandKoichi Wakataabout the progress of their mission.

At11 a.m.April 29, Aunon will participate in an Indianapolis Indians game at Victory Field. She will engage with the audience while showing video to promote human spaceflight and the benefits of the space station.

Aunon also will give a presentation for the public beginning at 5:30 p.m,April 29, at the Indiana State Museum. The presentation will be followed by a question-and-answer session and an opportunity for astronaut autographs.

Excerpt from:
NASA Astronauts Bring Wonder of International Space Station to Indianapolis

Posted in Space Station | Comments Off on NASA Astronauts Bring Wonder of International Space Station to Indianapolis

NASA Sets Preview Briefing, TV Schedule for Space Station Spacewalk

Posted: at 3:45 pm

Two NASA astronauts aboard the International Space Station will conduct a spacewalk in the coming week to replace a failed backup computer relay system on the space station's truss. The activity, designated U.S. EVA 26, will be broadcast live on NASA Television and previewed in a briefing at NASA's Johnson Space Center in Houston at 9:30 a.m. EDT Friday, April 18.

The briefing participants are: -- Mike Suffredini, International Space Station program manager -- Brian Smith, International Space Station flight director -- Glenda Brown, lead spacewalk officer

NASA astronauts Rick Mastracchio and Steve Swanson are scheduled to venture outside the space station Wednesday, April 23, to replace a backup multiplexer-demultiplexer (MDM) that failed during routine testing April 11. The box is one of the station's two external MDMs that provide commands to some of the space station's systems, including the external cooling system, solar alpha rotary joints and mobile transporter rail car.

NASA TV coverage of the April 23 spacewalk will begin at 8:30 a.m. The spacewalk is scheduled to begin at 9:20 a.m.

If Friday's SpaceX cargo launch to the station is postponed, the two Expedition 39 astronauts will conduct the spacewalk Sunday, April 20. NASA TV coverage would begin at 8 a.m. with the spacewalk scheduled to begin at 8:55 a.m.

Reporters may attend the spacewalk preview briefing in-person at Johnson or at other participating NASA centers. Media representatives who wish to ask questions by phone must call the Johnson newsroom at 281-483-5111 no later than 9:15 a.m.

The spacewalk will be the 179th in support of space station assembly and maintenance, the ninth in Mastracchios career and the fifth for Swanson. Mastracchio will carry the designation of EV 1, wearing the spacesuit bearing red stripes. Swanson will be EV 2, wearing the spacesuit without stripes.

For NASA TV streaming video, downlink and scheduling information, visit:

NASA TV Live

For b-roll and other media resources, visit:

See original here:
NASA Sets Preview Briefing, TV Schedule for Space Station Spacewalk

Posted in Space Station | Comments Off on NASA Sets Preview Briefing, TV Schedule for Space Station Spacewalk

Americans predict what the future looks like for technology

Posted: at 3:45 pm

Over the past 50 years, Americans have witnessed the first man walk on the moon, the birth of the Internet and cellphones, large and small and large again. What will the future of technology and science hold in the next 50 years? Controlled weather? Space colonization? Personal drone use?

Pew Research Center recently asked the American public about their predictions and hopes for the future of technology. The U.S. Views of Technology and the Future report, released Thursday, found that a majority of the more than 1,000 Americans surveyed believe that the next five decades will see the custom creation of transplantable organs, and computer-developed art, music and novels rivaling human talent. And while most dont believe the United States will see teleportation, space colonization or controlled weather, more people found those first two ideas more likely scenarios than the ability to choose which way the wind blows.

Most Americans dont think humans will be able to control the weather in the 50-year future.

Clearly nature holds a place in the popular imagination that even some of the most challenging engineering projects cant match, said senior researcher of Pew Research Centers Internet Project Aaron Smith.

When it comes to short-term changes regarding some controversial technological advancements, the majority is wary:

Pew notes its not that everyone is completely opposed to trying new technology. Theyre just inclined to let others take the first step.

Getting brain implants to improve memory or eating lab-grown meat, on the other hand, might not have many takers at all. Just twenty-six percent would (literally) change their minds, and only 20 percent were willing to try Franken-meat. But the opinion was nearly split on riding driverless cars, with 48 percent up for the challenge and 50 percent uninterested.

Were asking: What technological advancements are you looking forward to in the future? Tell us in the comments below.

Read the original here:
Americans predict what the future looks like for technology

Posted in Moon Colonization | Comments Off on Americans predict what the future looks like for technology

The Application of Genetic Engineering in Daily Life – Video

Posted: at 3:45 pm


The Application of Genetic Engineering in Daily Life
What is genetic engineering? Genetic engineering is the method to change the genetic structure of an organism to obtain its desired traits in the form of sim...

By: Savvy Centrinova

Here is the original post:
The Application of Genetic Engineering in Daily Life - Video

Posted in Genetic Engineering | Comments Off on The Application of Genetic Engineering in Daily Life – Video

Stanford scientists develop 'playbook' for reverse engineering tissue

Posted: at 3:45 pm

PUBLIC RELEASE DATE:

16-Apr-2014

Contact: Tom Abate tabate@stanford.edu 650-736-2245 Stanford University Medical Center

STANFORD, Calif. Consider the marvel of the embryo. It begins as a glob of identical cells that change shape and function as they multiply to become the cells of our lungs, muscles, nerves and all the other specialized tissues of the body.

Now, in a feat of reverse tissue engineering, Stanford University researchers have begun to unravel the complex genetic coding that allows embryonic cells to proliferate and transform into all of the specialized cells that perform myriad biological tasks.

A team of interdisciplinary researchers took lung cells from the embryos of mice, choosing samples at different points in the development cycle. Using the new technique of single-cell genomic analysis, they recorded what genes were active in each cell at each point. Though they studied lung cells, their technique is applicable to any type of cell.

"This lays out a playbook for how to do reverse tissue engineering," said Stephen Quake, PhD, the Lee Otterson Professor in the School of Engineering and a Howard Hughes Medical Institute investigator.

The researchers' findings are described in a paper published online April 13 in Nature. Quake, who also is a professor of bioengineering and of applied physics, is the senior author. The lead authors are postdoctoral scholars Barbara Treutlein, PhD, and Doug Brownfield, PhD.

The researchers used the reverse-engineering technique to study the cells in the alveoli, the small, balloon-like structures at the tips of the airways in the lungs. The alveoli serve as docking stations where blood vessels receive oxygen and deliver carbon dioxide.

Treutlein and Brownfield isolated 198 lung cells from mouse embryos at three stages of gestation: 14.5 days, 16.5 days and 18.5 days (mice are usually born at 20 days). They also took some lung cells from adult mice.

Read more:
Stanford scientists develop 'playbook' for reverse engineering tissue

Posted in Genetic Engineering | Comments Off on Stanford scientists develop 'playbook' for reverse engineering tissue

GMO Labeling Bill Passes Vermont Senate

Posted: at 3:45 pm

NEW YORK (TheStreet) -- In what could be a big win for opponents of genetically modified organisms, Vermont is one step closer to signing into law legislation that would require food companies to label products that contain GMOs in the Green Mountain State.

On Wednesday, the Vermont State Senate passed "An Act Relating to the Labeling of Food Produced with Genetic Engineering," H. 112, by a vote of 28-2. The state legislation, introduced in January 2013, proposes to provide that "food is misbranded if it is entirely or partially produced with genetic engineering and it is not labeled as genetically engineered." Sen. David Zuckerman is the bill's lead sponsor, according to the Brattleboro Reformer.

The bill will now go back to the House to approve the Senate's amendments and then to Gov. Peter Shumlin to sign into law. The act is supposed to become effective on July 1, 2016, according to Reuters.

Genetically modified organisms, or GMOs, are plants or animals that have been genetically engineered with DNA from bacteria, viruses or other plants and animals that cannot occur in natural crossbreeding, according to the Non-GMO Project, a non-profit organization dedication to the education of GMOs and helping consumers find alternatives and considered the main organization used by many companies to verify their non-GMO foods.

Continue reading here:
GMO Labeling Bill Passes Vermont Senate

Posted in Genetic Engineering | Comments Off on GMO Labeling Bill Passes Vermont Senate

Vermont Senate passes GMO labeling bill

Posted: at 3:45 pm

The Vermont Senate voted to pass a new law requiring labeling for foods that contain ingredients produced with genetic engineering or genetically modified ingredients (GMOs). If enacted, the law would be the first in the nation to require GMO labeling without any contingencies or similar legislation by adjoining states. The proposed effective date is July 1, 2016.

Although the Vermont House previously passed the bill, it will be returned for representatives to approve changes made by the Senate. Once approved, the bill will reach the governors office for signature into law.

It is estimated that 80% of all food sold in the United States is at least partially produced from genetic engineering. The bill would require labeling on all such food sold at retail in Vermont, regardless of whether the food was manufactured in Vermont.

While the bill exempts processing aids and milk from cows that have been fed GMO feed, many dairy products and other foods that incorporate milk would be affected unless they were made with organic ingredients.

The Food and Drug Administration, the American Medical Association, the World Health Organization, the U.S. Department of Agriculture and the National Academy of Sciences all have said that GMO ingredients are safe and there are no negative health effects associated with their use.

This bill would confuse consumers, raise food prices and do nothing to ensure product safety, said Ruth Saunders, IDFA vice president of policy and legislative affairs. Its too bad for the dairy industry that Vermont would require such labels on chocolate milk, yogurt and other healthy dairy products while offering an exemption to the entire alcoholic beverage sector.

The neighboring states of Connecticut and Maine already passed labeling laws, but each delayed implementation until at least four other adjoining states passed and implemented similar laws. This strategy is designed to protect them from lawsuits from companies and associations that want to safeguard consistency in food labeling and avoid a 50-state patchwork of laws. Vermont, however, has decided to go it alone and is preparing a war chest in anticipation of the lawsuits to come.

IDFA and many other trade organizations oppose individual state legislation on GMO labeling and fully support The Safe and Accurate Food Labeling Act of 2014, introduced by U.S. Reps. Mike Pompeo (R-KS) and G.K. Butterfield (D-NC). This bill would preempt states from requiring mandatory labeling and establish a federal standard for voluntary labeling of food and beverage products made with GMOs.

IDFA believes that a federal solution on GMO labeling would bolster consumer confidence in American food by affirming FDAs overall authority for setting the nations food safety and labeling regulations, said Saunders.

IDFA is working with the Safe and Affordable Food Coalition, headed by the Grocery Manufacturers Association, on all issues related to GMO labeling.

See the article here:
Vermont Senate passes GMO labeling bill

Posted in Genetic Engineering | Comments Off on Vermont Senate passes GMO labeling bill

Trait by trait, plant scientists swiftly weed out bad seeds through marker-assisted breeding

Posted: at 3:45 pm

When his tomato plants were just a week old, technicians manually punched a hole in each seedling to get leaf tissue that was taken to a nearby lab, converted into a chemical soup and then scanned for genetic markers linked to desired traits.

Krivanek uses the information to keep just 3percent of the seedlings and grow them until they fruit this spring, when he can evaluate fully grown plants, keep a few hundred, sow their seeds and then screen those plants.

Im improving my odds. Maybe I can introduce to market a real super-hybrid in five years, Krivanek said. A predecessor might take a whole career.

The technology called marker-assisted or molecular breeding is far removed from the better-known and more controversial field of genetic engineering, in which a plant or animal can receive genes from a different organism.

Marker-assisted breeding, by contrast, lays bare the inherent genetic potential of an individual plant to allow breeders to find the most promising seedling among thousands for further breeding. Because the plants natural genetic boundaries are not crossed, the resulting commercial hybrid is spared the regulatory gantlet and the public opposition focused on such plants as genetically modified Roundup Ready corn or soybeans, which are engineered to withstand herbicide sprays.

Marker-assisted breeding has been embraced not only by the multinational biotech companies here in Californias Central Valley but also by plant scientists in government, research universities and nongovernmental organizations fervently seeking new, overachieving crops. The goal is to sustainably feed an expanding global population while dealing with the extremes of climate change.

But critics of Big Agriculture worry about the needs of small-scale farmers and breeders. Low-tech conventional breeding judging plants by how they look and perform, not by their DNA has been the lifeblood of small seed companies and local growers, often in conjunction with breeding programs at land-grant universities. But those programs have shrunk by a third in recent years, and the remaining ones are increasingly gravitating to the trendy sphere of molecular breeding.

Organic farmers, who need crop varieties designed for specific regions and less-intensive growing methods, are not being served by the new applied science, said John Navazio, a senior scientist with the Organic Seed Alliance.

There used to be a significant winter spinach production area in southern Virginia and Delmarva, and thats completely gone, he said. The spinach-growing industry has moved to megagrowers in California and Arizona.

Progress comes sooner

See the original post here:
Trait by trait, plant scientists swiftly weed out bad seeds through marker-assisted breeding

Posted in Genetic Engineering | Comments Off on Trait by trait, plant scientists swiftly weed out bad seeds through marker-assisted breeding

Daniel J. Rader, MD, Named as Chair of the Department of Genetics at the Perelman School of Medicine at the University …

Posted: at 3:44 pm

PHILADELPHIA Daniel J. Rader, MD, a widely recognized international leader in the human genetics of lipoprotein biology and cardiovascular disease, has been named the new chair of the Department of Genetics in the Perelman School of Medicine at the University of Pennsylvania. He has been a faculty member at Penn for 20 years and is currently the chief of the Division of Translational Medicine and Human Genetics and the Edward S. Cooper, MD/Norman Roosevelt and Elizabeth Meriwether McLure Professor of Medicine.

As a prominent physician-scientist, Dr. Rader will bring his robust knowledge of genetic approaches to improving health to guide the department of Genetics into an era where genes play a role in our strategies to prevent and treat a broad array of diseases, said J. Larry Jameson, MD, PhD, Executive Vice President for the Health System and Dean of the Perelman School of Medicine. His long record of leadership in the classroom, the exam room, and the lab will be invaluable to the department and overall genetics research at Penn.

Dr. Rader holds multiple leadership roles at Penn Medicine. In addition to heading the Division of Translational Medicine and Human Genetics within the Department of Medicine, he also serves as Associate Director of the Institute for Translational Medicine and Therapeutics (ITMAT).

He co-directs the new Penn Medicine BioBank, an integrated, centralized resource for consenting, collecting, processing, and storing DNA, plasma/serum, and tissue for human genetics and translational research. This venture is a cornerstone of Penn Medicines efforts in human genetics and translational and personalized medicine. Dr. Rader also has key relationships with Penns Cardiovascular Institute (CVI) and Institute for Diabetes, Obesity, and Metabolism (IDOM).

In his research program, Dr. Rader has used human genetics and model systems to elucidate novel biological pathways in lipoprotein metabolism and atherosclerosis. His lab discovered and characterized the enzyme endothelial lipase, demonstrated its effects on high density lipoproteins (HDL) in mice, and then found that loss-of-function mutations in the gene cause high levels of HDL in humans. He is among the worlds leaders in using both humans and model systems to dissect the functional genomics of human genetic variants associated with plasma lipid traits as well as coronary heart disease.

He has had a long interest in Mendelian disorders of lipoprotein metabolism and has a strong translational interest in development of novel therapies for these disorders. He was involved in the identification of the molecular defect in a rare genetic disorder causing very low levels of low density lipoproteins (LDL), which spurred the development of inhibitors of this protein to reduce levels of LDL. Indeed, when one such drug was abandoned by a pharmaceutical firm, he went on to oversee its development for the orphan disease homozygous familial hypercholesterolemia (HoFH), characterized by extremely high levels of LDL and heart disease in childhood. This decade-long endeavor led to FDA and European approval of lomitapide, the first effective medication for the treatment of HoFH.

Dr. Rader has received numerous awards as a physician-scientist, including the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, the Bristol Myers Squibb Cardiovascular Research Award, the Doris Duke Charitable Foundation Distinguished Clinical Investigator Award, the Jeffrey M. Hoeg Award for Basic Science and Clinical Research from the American Heart Association, the American Heart Associations Clinical Research Prize, and the Clinical Research Forums Distinguished Clinical Research Award. He has been elected to the American Society of Clinical Investigation and to the Association of American Physicians. In 2011, he received one of the nations highest honors in biomedicine when he was elected to the Institute of Medicine.

Dr. Rader has also received many awards for his outstanding teaching activities. At the Perelman School of Medicine, he has received the William Osler Patient Oriented Research Award, as well as the Donald B. Martin Outstanding Teacher Award and the Outstanding Faculty Award from the Department of Medicine. Along with these accolades, Dr. Rader has been honored by Philadelphia magazine, which has named him to its Top Docs honor roll every year since 2002.

Dr. Rader earned his medical degree at the Medical College of Pennsylvania, followed by an internship and a residency at Yale-New Haven Hospital. Next, he served as a post-doctoral fellow at the National Institutes of Health, where he developed skills in basic science as well as translational research involving patients with genetic lipid disorders.

See the article here:
Daniel J. Rader, MD, Named as Chair of the Department of Genetics at the Perelman School of Medicine at the University ...

Posted in Human Genetics | Comments Off on Daniel J. Rader, MD, Named as Chair of the Department of Genetics at the Perelman School of Medicine at the University …